These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8135493

  • 1. Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.
    Quak J, Gerretsen M, De Bree R, Brakenhof R, Van Dongen G, Snow G.
    Anticancer Res; 1993; 13(6B):2533-9. PubMed ID: 8135493
    [Abstract] [Full Text] [Related]

  • 2. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
    van Dongen GA, Brakenhoff RM, ten Brink CT, van Gog FB, de Bree R, Quak JJ, Snow GB.
    Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies (Mabs) in head and neck cancer.
    Poliquin JF, Filion LG.
    J Otolaryngol; 1986 Oct; 15(5):289-92. PubMed ID: 3534285
    [Abstract] [Full Text] [Related]

  • 4. [Monoclonal antibody UW 21/123: clinical use and diagnostic specificity in head and neck cancers].
    Zenner HP, Herrmann IF, Moser L.
    Laryngol Rhinol Otol (Stuttg); 1986 May; 65(5):287-91. PubMed ID: 3016433
    [Abstract] [Full Text] [Related]

  • 5. [Possible applications for monoclonal antibodies in diagnosis and therapy of head and neck cancers. II. Future role].
    Wustrow TP.
    HNO; 1991 Apr; 39(4):121-8. PubMed ID: 2066263
    [Abstract] [Full Text] [Related]

  • 6. [Possibilities for using monoclonal antibodies in diagnosis and therapy of head and neck cancers. I. Introduction and current state].
    Wustrow TP.
    HNO; 1991 Mar; 39(3):82-90. PubMed ID: 2050556
    [Abstract] [Full Text] [Related]

  • 7. [Monoclonal antibodies to lung cancer antigens (a review of the literature)].
    Tkacheva GA.
    Med Radiol (Mosk); 1989 May; 34(5):62-75. PubMed ID: 2542715
    [No Abstract] [Full Text] [Related]

  • 8. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
    Fantozzi RD.
    Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO, Alhamarneh O, Stafford ND, Greenman J.
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [Abstract] [Full Text] [Related]

  • 10. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H, Eccles S, Sandle J, Box G, Titley J, Dean C.
    Cancer Res; 1994 Apr 01; 54(7):1695-701. PubMed ID: 8137284
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA.
    Cancer Res; 1993 Aug 01; 53(15):3524-9. PubMed ID: 8339258
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48.
    Quak JJ, Gerretsen M, Schrijvers AH, Meijer CJ, van Dongen GA, Snow GB.
    Arch Otolaryngol Head Neck Surg; 1991 Nov 01; 117(11):1287-91. PubMed ID: 1747235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.